COVID-19 Impact on Global Latent Tuberculosis Infection (LTBI) Testing Market Size, Status and Forecast 2020-2026

Published On: Jun 2020

Format: PDF

Publisher: QY Research

Pages: 93

Report ID: 177414

This report focuses on the global Latent Tuberculosis Infection (LTBI) Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Latent Tuberculosis Infection (LTBI) Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Qiagen
BioMerieux
Thermo Fisher Scientific
Danaher
Roche
Becton Dickinson
Agilent Technologies
Bio-Rad Laboratories
Eppendorf
Abbott Laboratories

Market segment by Type, the product can be split into
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Others
Market segment by Application, split into
Household Contacts with Pulmonary TB
PLHIV
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Latent Tuberculosis Infection (LTBI) Testing status, future forecast, growth opportunity, key market and key players.
To present the Latent Tuberculosis Infection (LTBI) Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Latent Tuberculosis Infection (LTBI) Testing are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Latent Tuberculosis Infection (LTBI) Testing Revenue
1.4 Market Analysis by Type
1.4.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Tuberculin Skin Test (TST)
1.4.3 Interferon Gamma Released Assay (IGRA)
1.4.4 Others
1.5 Market by Application
1.5.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Application: 2020 VS 2026
1.5.2 Household Contacts with Pulmonary TB
1.5.3 PLHIV
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Latent Tuberculosis Infection (LTBI) Testing Industry Impact
1.6.1 How the Covid-19 is Affecting the Latent Tuberculosis Infection (LTBI) Testing Industry
1.6.1.1 Latent Tuberculosis Infection (LTBI) Testing Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Latent Tuberculosis Infection (LTBI) Testing Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Latent Tuberculosis Infection (LTBI) Testing Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Global Growth Trends by Regions
2.1 Latent Tuberculosis Infection (LTBI) Testing Market Perspective (2015-2026)
2.2 Latent Tuberculosis Infection (LTBI) Testing Growth Trends by Regions
2.2.1 Latent Tuberculosis Infection (LTBI) Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Latent Tuberculosis Infection (LTBI) Testing Historic Market Share by Regions (2015-2020)
2.2.3 Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Latent Tuberculosis Infection (LTBI) Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Latent Tuberculosis Infection (LTBI) Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Market Size
3.1.1 Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Revenue (2015-2020)
3.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Concentration Ratio
3.2.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Latent Tuberculosis Infection (LTBI) Testing Revenue in 2019
3.3 Latent Tuberculosis Infection (LTBI) Testing Key Players Head office and Area Served
3.4 Key Players Latent Tuberculosis Infection (LTBI) Testing Product Solution and Service
3.5 Date of Enter into Latent Tuberculosis Infection (LTBI) Testing Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Latent Tuberculosis Infection (LTBI) Testing Historic Market Size by Type (2015-2020)
4.2 Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Type (2021-2026)

5 Latent Tuberculosis Infection (LTBI) Testing Breakdown Data by Application (2015-2026)
5.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)
5.2 Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Latent Tuberculosis Infection (LTBI) Testing Market Size (2015-2020)
6.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in North America (2019-2020)
6.3 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020)
6.4 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)

7 Europe
7.1 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size (2015-2020)
7.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in Europe (2019-2020)
7.3 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020)
7.4 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)

8 China
8.1 China Latent Tuberculosis Infection (LTBI) Testing Market Size (2015-2020)
8.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in China (2019-2020)
8.3 China Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020)
8.4 China Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)

9 Japan
9.1 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size (2015-2020)
9.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in Japan (2019-2020)
9.3 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020)
9.4 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size (2015-2020)
10.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)

11 India
11.1 India Latent Tuberculosis Infection (LTBI) Testing Market Size (2015-2020)
11.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in India (2019-2020)
11.3 India Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020)
11.4 India Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size (2015-2020)
12.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020)
12.4 Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Qiagen
13.1.1 Qiagen Company Details
13.1.2 Qiagen Business Overview and Its Total Revenue
13.1.3 Qiagen Latent Tuberculosis Infection (LTBI) Testing Introduction
13.1.4 Qiagen Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020))
13.1.5 Qiagen Recent Development
13.2 BioMerieux
13.2.1 BioMerieux Company Details
13.2.2 BioMerieux Business Overview and Its Total Revenue
13.2.3 BioMerieux Latent Tuberculosis Infection (LTBI) Testing Introduction
13.2.4 BioMerieux Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
13.2.5 BioMerieux Recent Development
13.3 Thermo Fisher Scientific
13.3.1 Thermo Fisher Scientific Company Details
13.3.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
13.3.3 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Introduction
13.3.4 Thermo Fisher Scientific Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
13.3.5 Thermo Fisher Scientific Recent Development
13.4 Danaher
13.4.1 Danaher Company Details
13.4.2 Danaher Business Overview and Its Total Revenue
13.4.3 Danaher Latent Tuberculosis Infection (LTBI) Testing Introduction
13.4.4 Danaher Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
13.4.5 Danaher Recent Development
13.5 Roche
13.5.1 Roche Company Details
13.5.2 Roche Business Overview and Its Total Revenue
13.5.3 Roche Latent Tuberculosis Infection (LTBI) Testing Introduction
13.5.4 Roche Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
13.5.5 Roche Recent Development
13.6 Becton Dickinson
13.6.1 Becton Dickinson Company Details
13.6.2 Becton Dickinson Business Overview and Its Total Revenue
13.6.3 Becton Dickinson Latent Tuberculosis Infection (LTBI) Testing Introduction
13.6.4 Becton Dickinson Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
13.6.5 Becton Dickinson Recent Development
13.7 Agilent Technologies
13.7.1 Agilent Technologies Company Details
13.7.2 Agilent Technologies Business Overview and Its Total Revenue
13.7.3 Agilent Technologies Latent Tuberculosis Infection (LTBI) Testing Introduction
13.7.4 Agilent Technologies Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
13.7.5 Agilent Technologies Recent Development
13.8 Bio-Rad Laboratories
13.8.1 Bio-Rad Laboratories Company Details
13.8.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
13.8.3 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Introduction
13.8.4 Bio-Rad Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
13.8.5 Bio-Rad Laboratories Recent Development
13.9 Eppendorf
13.9.1 Eppendorf Company Details
13.9.2 Eppendorf Business Overview and Its Total Revenue
13.9.3 Eppendorf Latent Tuberculosis Infection (LTBI) Testing Introduction
13.9.4 Eppendorf Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
13.9.5 Eppendorf Recent Development
13.10 Abbott Laboratories
13.10.1 Abbott Laboratories Company Details
13.10.2 Abbott Laboratories Business Overview and Its Total Revenue
13.10.3 Abbott Laboratories Latent Tuberculosis Infection (LTBI) Testing Introduction
13.10.4 Abbott Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
13.10.5 Abbott Laboratories Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details